Open AccessAntiplatelet Therapy in Acute Cerebral Ischemia
Author(s) -
Martin M. Bednar,
Cordell E. Gross
Publication year - 1999
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.30.4.887
Subject(s) - medicine , aspirin , clopidogrel , dipyridamole , stroke (engine) , tissue plasminogen activator , ticlopidine , adverse effect , anesthesia , cardiology , mechanical engineering , engineering
Improved recognition of stroke signs and symptoms has paralleled the development of pharmacological strategies that may be examined to reduce stroke mortality and morbidity. Presently, tissue plasminogen activator is the only therapy that significantly improves outcome in acute stroke, with no agent demonstrating a significant reduction in mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom